PMID: 9535235Apr 16, 1998Paper

Drug therapy in juvenile dermatomyositis: follow-up study

Journal of Child Neurology
Y T NgT Wu

Abstract

A series of 33 patients with juvenile dermatomyositis was reviewed in terms of their prognosis in relation to their drug therapy. This retrospective study was intended to help clarify the use of various therapies in this rare, heterogeneous disease from our hospital's experience in the last 24 years. The results confirmed that oral corticosteroids should remain the undisputed first line of treatment. For more refractory, chronic patients, the results suggest that azathioprine should be the favored drug of first choice (in addition to corticosteroids). There may be a role for cyclosporine as a "rescue" treatment, but this needs to be further defined.

References

Feb 13, 1975·The New England Journal of Medicine·A Bohan, J B Peter
Aug 1, 1992·The Journal of Dermatology·T HiketaR Sasaki
Oct 1, 1992·Arthritis and Rheumatism·L C MillerJ G Schaller
Aug 1, 1991·The American Journal of Medicine·B A LangC M Roifman
Jan 1, 1990·Brain & Development·I Gamstorp
Feb 1, 1990·Journal of the American Academy of Dermatology·P Dantzig
May 13, 1989·Lancet·J HeckmattV Dubowitz
Mar 1, 1985·Annals of Neurology·F L Mastaglia, V J Ojeda
Jan 1, 1988·The Journal of Pediatrics·E GirardinL Paunier
Feb 11, 1984·Lancet·P ZabelW L Gross
Sep 1, 1984·The Journal of Pediatrics·C H SpencerK K King
Jan 1, 1983·Dermatologica·T YanagisawaA Kumagai
Jun 1, 1983·Archives of Disease in Childhood·G MillerV Dubowitz
Sep 1, 1995·Current Opinion in Rheumatology·L M Pachman

❮ Previous
Next ❯

Citations

Jun 12, 2013·American Journal of Clinical Dermatology·Alisa N FemiaJeffrey P Callen
Oct 30, 2013·International Journal of Rheumatic Diseases·Peter J GowdieJonathan D Akikusa
Apr 12, 2006·Annals of the Rheumatic Diseases·I M BronnerJ E Hoogendijk
Jan 1, 2000·Lancet·J P Callen
Nov 24, 2005·Current Rheumatology Reports·Adam Huber, Brian M Feldman
Jul 12, 2011·Autoimmunity Reviews·Isabelle Marie, Luc Mouthon
Apr 22, 2008·Journal of the American Academy of Dermatology·Luciano J Iorizzo, Joseph L Jorizzo
Feb 22, 2011·La Presse médicale·Isabelle Marie
Aug 24, 2016·Journal of Clinical Neuromuscular Disease·Hafiz A ElahiJohn N Whitaker
Aug 16, 2016·Annals of the Rheumatic Diseases·Felicitas Bellutti EndersAnnet van Royen-Kerkhof
Feb 9, 2021·Current Rheumatology Reports·Ovgu Kul CinarClarissa A Pilkington
Jul 29, 2000·Seminars in Pediatric Neurology·N F Schor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Rheumatology
R W Keen, J M Gumpel
Journal of the American Academy of Dermatology
M E Zieglschmid-AdamsR D Sontheimer
Journal of Pediatric Gastroenterology and Nutrition
Judith M Sondheimer
© 2022 Meta ULC. All rights reserved